Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patients
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 46, 102466
Abstract
No abstract availableKeywords
Funding Information
- Baqiyatallah University of Medical Sciences
This publication has 49 references indexed in Scilit:
- MicroRNAs in autoimmunity and inflammatory bowel disease: Crucial regulators in immune responseAutoimmunity Reviews, 2012
- Ozone therapy: A clinical reviewJournal of Natural Science, Biology and Medicine, 2011
- MicroRNAs in Sjögren's syndrome as a prototypic autoimmune diseaseAutoimmunity Reviews, 2010
- MicroRNAs and deregulated gene expression networks in neurodegenerationBrain Research, 2010
- Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy ControlsPLOS ONE, 2009
- MicroRNA in autoimmunity and autoimmune diseasesJournal of Autoimmunity, 2009
- Multiple sclerosisThe Lancet, 2008
- Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple SclerosisThe American Journal of Pathology, 2008
- Phenotypic and functional features of human Th17 cellsJournal of Experimental Medicine, 2007
- Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosisBrain, 2005